Science in Vision
17
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
5.9%
1 terminated/withdrawn out of 17 trials
94.1%
+7.6% vs industry average
24%
4 trials in Phase 3/4
100%
16 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Quatera 700 vs. Centurion
Role: collaborator
Vivity IOL: Emmetropia Compared to Monovision.
Role: collaborator
Vault Evaluation After ICL Implantation
Role: collaborator
Symfony vs Vivity in Dim Light
Role: collaborator
Symfony/Synergy IOL Combination Outcomes
Role: collaborator
Synergy Lens Outcomes Evaluation
Role: collaborator
Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens
Role: collaborator
AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study
Role: collaborator
Clinical and Refractive Outcomes After Contoura® Refractive Surgery Planned Using Phorcides Surgery Planning Software
Role: collaborator
The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens
Role: collaborator
Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen
Role: collaborator
Spectacle Independence and Overall Satisfaction With AcrySof® Panoptix® Toric Intraocular Lens
Role: collaborator
Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes
Role: collaborator
Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes
Role: collaborator
Symfony Toric Intraocular Lens Visual Outcomes
Role: collaborator
Conventional Surgery vs. Verion/VerifEye
Role: collaborator
Dropless vs. Standard Drops Contralateral Eye Study
Role: collaborator
All 17 trials loaded